Confaloni Annamaria, Crestini Alessio, Albani Diego, Piscopo Paola, Campeggi Lorenzo Malvezzi, Terreni Liana, Tartaglia Marco, Forloni Gianluigi
Department of Cellular Biology and Neuroscience, Istituto Superiore di Sanità, 299 Viale Regina Elena, 00161 Rome, Italy.
Brain Res Mol Brain Res. 2005 May 20;136(1-2):12-22. doi: 10.1016/j.molbrainres.2004.12.022. Epub 2005 Mar 16.
Nicastrin is a type 1 transmembrane glycoprotein that interacts with presenilin, Aph-1, and Pen-2 proteins to form a high molecular complex with gamma secretase activity. Then, nicastrin has a central role in presenilin-mediated processing of beta-amyloid precursor protein and in some aspects of Notch/glp-1 signaling in vivo. Here, we isolated a rat nicastrin cDNA and investigated gene expression in embryonic and adult rat tissues. The predicted amino acid sequence is comprised of 708 residues and showed a high degree of identity with other vertebrate orthologs. Besides full-length nicastrin mRNA, we identified an alternative spliced variant lacking the whole exon 3 and predicted to encode a 62-residue-long truncated protein. Full-length nicastrin mRNA was observed to be ubiquitously expressed, while the spliced variant was preferentially transcribed in the nervous system, whether in embryonic or adult neural tissues. Studies performed on primary cell cultures demonstrated that the short isoform was expressed in neurons, but not in astrocyte and microglial cells. Further experiments performed to verify the presence of the variant in neuroblastoma culture failed to show any truncated protein. Treatments by cyclohexamide showed the involvement of a quality control-based surveillance mechanism, which selectively degrades the exon 3-skipped isoform. In summary, this is the first report describing a novel skipped isoform of nicastrin which may suggest a new possible control mechanism based on the alternative splicing and nonsense-mediated mRNA decay to regulate brain protein expression and provide newer insights into potential implication in Alzheimer's disease.
尼卡斯特林是一种1型跨膜糖蛋白,它与早老素、Aph-1和Pen-2蛋白相互作用,形成具有γ-分泌酶活性的高分子复合物。然后,尼卡斯特林在早老素介导的β-淀粉样前体蛋白加工以及体内Notch/glp-1信号传导的某些方面发挥核心作用。在这里,我们分离出大鼠尼卡斯特林cDNA,并研究其在胚胎和成年大鼠组织中的基因表达。预测的氨基酸序列由708个残基组成,与其他脊椎动物直系同源物具有高度同源性。除了全长尼卡斯特林mRNA外,我们还鉴定出一种选择性剪接变体,该变体缺少整个外显子3,预计编码一个62个残基长的截短蛋白。观察到全长尼卡斯特林mRNA在各处均有表达,而剪接变体在神经系统中优先转录,无论是在胚胎还是成年神经组织中。对原代细胞培养物进行的研究表明,短异构体在神经元中表达,但在星形胶质细胞和小胶质细胞中不表达。为验证神经母细胞瘤培养物中变体的存在而进行的进一步实验未能显示任何截短蛋白。环己酰亚胺处理表明存在基于质量控制的监测机制,该机制选择性地降解跳过外显子3的异构体。总之,这是第一份描述尼卡斯特林一种新型跳过异构体的报告,这可能提示一种基于选择性剪接和无义介导的mRNA衰变的新的可能控制机制,以调节脑蛋白表达,并为其在阿尔茨海默病中的潜在影响提供新的见解。